Provider concentration
The single largest discount in the category. If one injector drives the revenue, that is the risk a buyer prices against. Spread production across a retained team.
For med spa & aesthetics owners
Aesthetics is consolidating and platforms are buying. But if most of the revenue runs through one set of hands, usually yours, a buyer sees risk and prices it hard. If you are thinking about selling, work with an advisor who knows what aesthetics buyers pay for and how to build a business that survives your exit.
Every conversation is confidential. No pressure, no obligation.
The problem
Most med spas are built around a great injector who is also the owner. That works beautifully until you try to sell, because a buyer is not buying you, and they know clients follow providers, not logos. If the revenue and the relationships live with one person, the business is worth a fraction of what the top line suggests.
The owners who sell well turn a client list into an operation: multiple providers who retain their own clients, recurring membership revenue, and a compliance structure that survives scrutiny. That transformation takes time, which is why it starts long before you decide to sell.
Buyers price each of these. The first one is the whole ballgame.
The single largest discount in the category. If one injector drives the revenue, that is the risk a buyer prices against. Spread production across a retained team.
Memberships and packages make income predictable, and predictable income is worth more than the same dollars earned one visit at a time.
Medical director and ownership arrangements that fit Texas rules. A clean structure clears diligence; a questionable one stalls or reprices the deal.
What you own versus lease, and whether those leases transfer, affects both margin and the mechanics of the sale.
If the brand is your face and your personal following, a buyer has to replace that. Build a brand that is the business, not the owner.
Honest accounting for deferred revenue and unredeemed packages. Buyers test it, and surprises here cost trust and price.
Every one is a form of the same question: how much of this depends on you? See owner dependence: selling a business that needs you.
Aesthetics operates inside medical regulation, and buyers look at how the practice is structured before they look at almost anything else. In Texas, the way a med spa is owned and the way the medical director and providers are arranged need to fit the state's rules on the corporate practice of medicine and on delegation and supervision. Buyers also review device and equipment leases, provider licensing and training records, treatment protocols, and consent documentation as part of diligence. This page is general information, not legal advice. The practical point for an owner is simple: have a healthcare attorney confirm your structure early, because compliance questions are far cheaper to resolve a year before a sale than to explain at the closing table.
Aesthetics platforms, many of them private-equity-backed, are rolling up med spas to build multi-location groups, and they pay the most for practices with multiple retained providers, real membership revenue, and a clean compliance structure. Larger regional med spa groups expand by acquisition. Individual operators and injectors buy smaller single-location practices. Each values yours differently and structures the deal differently, often with rollover equity or an earnout. My job is to put the right buyers in competition so you set the price, the cash at closing, and your role afterward.
One advisor who understands the business, with two firms behind the deal.
First we get the business ready: clean, accrual financials with honest treatment of memberships and deferred revenue, a clear read on provider concentration, and a structure that will hold up in diligence, handled through Thryve Accounting & Advisory, ideally a year or two before you go to market. Then we position the business, build a targeted list of the aesthetics buyers who would pay a premium for it, and run a disciplined process that creates real competition. The transaction is executed through Optima Mergers & Acquisitions, a Dallas middle-market investment bank named to Axial's Advisor 100.
Questions owners ask
Provider concentration, by a wide margin. If one injector, often the owner, produces most of the revenue and holds the client relationships, a buyer sees the business walking out the door the day that person leaves. It is the single largest discount in the category. The fix is to build a team of providers with loyal followings of their own and move client relationships onto the business, so revenue does not depend on any one set of hands.
Start a year or two out. Reducing provider concentration is not a last-month fix, because a buyer wants to see that new injectors have ramped, retained clients, and produce reliably. The earlier you build the bench and show it working, the more the business reads as a durable operation rather than a personal client list, and the better your leverage when buyers compete.
Yes, when it is real. Recurring membership and package revenue makes future income more predictable, and predictable revenue is worth more to a buyer than the same dollars earned one visit at a time. What matters is the quality: genuine retention, honest accounting of deferred and unredeemed balances, and members who actually return.
Aesthetics sits inside medical regulation, and buyers examine the structure closely. In Texas, how the practice is owned and how the medical director and providers are arranged has to fit the state's rules on the corporate practice of medicine and on delegation and supervision. Buyers also look at device leases, provider licensing and training records, protocols, and consent documentation. This is not legal advice; have a healthcare attorney confirm your structure well before a sale. Treat it as a diligence issue that is cheaper to clean up early.
The first call is free, thirty minutes, and completely confidential. Tell me where the business stands and I will tell you straight what a buyer will see and what is worth doing before you go to market.
Book a confidential call